Intra-cellular Therapies, Inc.

This study is testing whether a new medication called ITI-1284 can help adults with moderate to severe generalized anxiety disorder (GAD) who haven't gotten enough relief from at least two standard anxiety treatments. About 570 participants will be randomly assigned to receive ei…

This study is testing whether a new drug called ITI-1284 can help adults with moderate-to-severe generalized anxiety disorder (GAD) who haven't gotten enough relief from their current standard medication. About 705 participants will take either the new drug at one of two doses or…

This study is testing whether an investigational drug called ITI-1284 can safely reduce agitation in people with Alzheimer's dementia. About 320 participants will be randomly assigned to receive either the drug or a placebo for 12 weeks. The main goal is to see if the drug helps …

This study is testing whether an investigational drug called ITI-1284 can help reduce distressing psychosis symptoms—like hallucinations and paranoid thoughts—in people with Alzheimer's disease. About 370 participants will be randomly assigned to receive either the study drug or …